Discussions regarding a Phase II, Multicentre, Randomized, Double-Blind, Placebo Controlled, parallel group study to evaluate efficacy, safety and tolerability of three doses of MT-7117 in patients with Erythropoietic Protoporphyria

Project Details

Short titleP:KAE Discussions regarding
StatusFinished
Effective start/end date30/03/1729/03/20

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.